Theravance Biopharma, Inc. · NASDAQ:TBPH
Winningham Rick E had 20,038 Theravance Biopharma, Inc. shares withheld for tax (Form 4)
Traded May 20, 2026 · Filed May 22, 2026
On May 20, 2026, Winningham Rick E (Director, CHIEF EXECUTIVE OFFICER) had 20,038 Theravance Biopharma, Inc. shares withheld for tax at US$16.55 for US$332K, leaving 1,631,056 shares. Filed May 22, 2026 (Form 4).
- Withheld for tax
- 20,038 shares
- Price
- US$16.55
- Value
- US$332K
- Holding after
- 1,631,056 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 20, 2026 | Ordinary Shares | Shares withheld for tax | 20,038 | US$16.55 | 1,631,056 | Direct |
Source
Related
- Theravance Biopharma, Inc.
- Winningham Rick E
- Theravance Biopharma, Inc. shareholders
- Form 4 · Winningham Rick E · Sep 24, 2026
- Form 4 · Winningham Rick E · Aug 24, 2026
- Form 4 · Winningham Rick E · Apr 3, 2026
- Form 4 · Weiss Asset Management LP · Sep 28, 2026
- Schedule 13D/A · Weiss Asset Management LP · Sep 25, 2026
- Form 4 · Pakianathan Deepika · Sep 24, 2026
- Form 4 · O'Connor Donal · Sep 24, 2026
- Form 4 · Mitchell Dean J · Sep 24, 2026